New Orleans, Louisiana
Partnering to Deliver Precision Cancer Therapy in the Community
Through an innovative partnership with the Translational Genomics Institute (TGen), the Ochsner Precision Cancer Therapies Program enables cutting-edge treatment to be available to cancer patients across the Gulf South region. This program has made early (Phase I and II) clinical cancer trials a viable option within their local community, while driving molecular diagnostic and clinical strategy, including next generation sequencing of tumor specimens.
Read Blog Visit Website